Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2630 to 2679 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2630\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 198 (fused in myeloproliferative disorders protein) (rearranged in atypical myeloproliferative disorder protein). [source:swissprot;acc:q9ubw7]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
224.891\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
225.195\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00135\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2631\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin-like protein 3 (actin-related protein 3) (actin-2). [source:swissprot;acc:p32391]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2632\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arp2/3 complex 21 kda subunit (p21-arc) (actin-related protein 2/3 complex subunit 3). [source:swissprot;acc:o15145]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2633\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nardilysin precursor (ec 3.4.24.61) (n-arginine dibasic convertase) (nrd convertase) (nrd-c). [source:swissprot;acc:o43847]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2634\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin-related protein 2/3 complex subunit 1a (sop2-like protein). [source:swissprot;acc:q92747]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2635\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna cleavage complex ii protein clp1. [source:swissprot;acc:q92989]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
166.612\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
166.393\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00132\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2636\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
anaphase promoting complex subunit 11 (hepatocellular carcinoma associated ring finger protein) (hspc214). [source:swissprot;acc:q9nyg5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
195.635\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
195.384\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00128\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2637\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
small glutamine rich protein with tetratricopeptide repeats 2. [source:refseq;acc:nm\_019072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.075\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
186.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00126\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2638\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctional adhesion molecule 1 precursor (jam) (platelet adhesion molecule 1) (pam-1) (platelet f11 receptor). [source:swissprot;acc:q9y624]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.911\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.168\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00125\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2639\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin viia. [source:swissprot;acc:q13402]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
220.658\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.386\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00123\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2640\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 b (ec 6.3.2.19) (ubiquitin-protein ligase b) (ubiquitin carrier protein b) (hr6b) (hhr6b) (e2-17 kda). [source:swissprot;acc:p23567]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2641\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 a (ec 6.3.2.19) (ubiquitin-protein ligase a) (ubiquitin carrier protein a) (hr6a) (hhr6a). [source:swissprot;acc:p49459]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2642\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
topoisomerase (dna) ii binding protein. [source:refseq;acc:nm\_007027]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
194.097\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
194.328\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00119\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2643\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coenzyme a oxidase 1, peroxisomal (ec 1.3.3.6) (palmitoyl-coa oxidase) (aox). [source:swissprot;acc:q15067]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2644\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase f chain, mitochondrial (ec 3.6.3.14). [source:swissprot;acc:p56134]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2645\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable atp-dependent helicase ddx35 (deah-box protein 35). [source:swissprot;acc:q9h5z1]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2646\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tsc22-related inducible leucine zipper protein 2 (tsc-22-like protein thg-1). [source:swissprot;acc:q9y3q8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.169\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.417\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00116\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2647\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
s-adenosylmethionine synthetase alpha and beta forms (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-i/iii). [source:swissprot;acc:q00266]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.496\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.25\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2648\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sphingolipid delta 4 desaturase; membrane fatty acid (lipid) desaturase; dihydroceramide desaturase. [source:refseq;acc:nm\_003676]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.169\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.417\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2649\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nif3-like protein 1 (amyotrophic lateral sclerosis 2 chromosomal region candidate gene protein 1) (my018 protein) (mds015). [source:swissprot;acc:q9gzt8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.874\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00114\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2650\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kh-type splicing regulatory protein (fuse binding protein 2); kh-type splicing regulatory protein (fuse-binding protein 2). [source:refseq;acc:nm\_003685]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.188\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.942\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00113\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2651\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nf-kappab inhibitor epsilon (nf-kappa-bie) (i-kappa-b-epsilon) (ikappabepsilon) (ikb-epsilon) (ikbe). [source:swissprot;acc:o00221]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
201.37\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.594\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00111\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2652\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear factor nf-kappa-b p105 subunit (dna-binding factor kbf1) (ebp- 1) [contains: nuclear factor nf-kappa-b p50 subunit]. [source:swissprot;acc:p19838]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
201.451\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.673\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0011\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2653\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nf-kappab inhibitor beta (nf-kappa-bib) (i-kappa-b-beta) (ikappabbeta) (ikb-beta) (ikb-b) (thyroid receptor interacting protein 9) (tr- interacting protein 9). [source:swissprot;acc:q15653]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
201.452\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
201.674\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2654\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear factor nf-kappa-b p100/p49 subunits (h2tf1) (oncogene lyt-10) (lyt10) [contains: nuclear factor nf-kappa-b p52 subunit]. [source:swissprot;acc:q00653]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2655\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
b-cell lymphoma 3-encoded protein (bcl-3 protein). [source:swissprot;acc:p20749]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
201.445\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.667\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2656\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
far upstream element-binding protein; far upstream element binding protein; fuse-binding protein. [source:refseq;acc:nm\_003902]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.179\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.943\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00109\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2657\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
channel associated protein of synapse-110 (chapsyn-110) (discs, large homolog 2). [source:swissprot;acc:q15700]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.934\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.7\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00108\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2658\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
presynaptic density protein 95 (psd-95) (discs, large homolog 4) (postsynaptic density-95). [source:swissprot;acc:p78352]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
216.933\vspace{3pt}}}&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2659\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
presynaptic protein sap102 (synapse-associated protein 102) (neuroendocrine-dlg) (ne-dlg) (discs, large homolog 3). [source:swissprot;acc:q92796]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2660\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
presynaptic protein sap97 (synapse-associated protein 97) (discs, large homolog 1) (hdlg). [source:swissprot;acc:q12959]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.937\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.704\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2661\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fes/fps (ec 2.7.1.112) (c-fes). [source:swissprot;acc:p07332]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
204.768\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
204.549\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00107\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2662\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
molybdenum cofactor synthesis protein 2 large subunit (molybdopterin synthase large subunit) (mpt synthase large subunit) (mocs2b) (moco1- b). [source:swissprot;acc:o96007]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2663\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
anaphase-promoting complex subunit 10; anaphase-promoting complex 10. [source:refseq;acc:nm\_014885]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2664\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l29 (cell surface heparin binding protein hip). [source:swissprot;acc:p47914]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2665\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fer (ec 2.7.1.112) (p94-fer) (c-fer). [source:swissprot;acc:p16591]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2666\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin domain containing; thioredoxin-related transmembrane protein; thioredoxin domain-containing. [source:refseq;acc:nm\_030755]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.136\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.911\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2667\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
molybdenum cofactor synthesis protein 3 (molybdopterin synthase sulfurylase) (mpt synthase sulfurylase). [source:swissprot;acc:o95396]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.768\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.549\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2668\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fuse binding protein 3 (fragment). [source:sptrembl;acc:q92946]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.176\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.944\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2669\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycerol-3-phosphate dehydrogenase [nad+], cytoplasmic (ec 1.1.1.8) (gpd-c) (gpdh-c). [source:swissprot;acc:p21695]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.575\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.354\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00103\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2670\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transforming protein p21a (k-ras 2a) (ki-ras) (c-k-ras). [source:swissprot;acc:p01116]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
144.391\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
144.538\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00102\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to glucosamine-phosphate n-acetyltransferase (hypothetical protein flj33258). [source:sptrembl;acc:q96ek6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.288\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.067\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2672\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
branched-chain amino acid aminotransferase, cytosolic (ec 2.6.1.42) (bcat(c)) (eca39 protein). [source:swissprot;acc:p54687]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.957\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.741\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2673\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad9 homolog; cell cycle checkpoint control protein; rad9 homolog (s. pombe). [source:refseq;acc:nm\_004584]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.372\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.588\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.001\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2674\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamine synthetase (ec 6.3.1.2) (glutamate--ammonia ligase). [source:swissprot;acc:p15104]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
203.151\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.948\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2675\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s26, mitochondrial precursor (mrp-s26) (mrp- s13). [source:swissprot;acc:q9byn8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
214.893\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.108\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2676\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
enhancer of rudimentary homolog. [source:swissprot;acc:q14259]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2677\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat protein shoc-2 (ras-binding protein sur-8). [source:swissprot;acc:q9uq13]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
144.412\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
144.553\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00098\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2678\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator-like 2 (ralgds-like factor) (ras-associated protein rab2l). [source:swissprot;acc:o15211]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
144.411\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
144.552\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2679\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
anaphase-promoting complex subunit 2; anaphase-promoting complex 2. [source:refseq;acc:nm\_013366]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
190.142\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
189.959\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00096\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/